Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in Anatolian shepherd dog monocytes

Journal of Veterinary Medicine, Series B

Volumn 49, Issue 6, 2002, Pages 289-293

  Ba A L ^a   Simsek A ^a   Corlu M ^a   Yazar, E ^a   Elmas, M ^a   Deim, Z G ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG CARRIER; ENROFLOXACIN; LIPOSOME; PHOSPHATIDYLCHOLINE; QUINOLONE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DOG; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MICROCAPSULE; MONOCYTE; REFERENCE VALUE; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FLUOROQUINOLONES; LIPOSOMES; MALE; MONOCYTES; PHOSPHATIDYLCHOLINES; QUINOLONES; REFERENCE VALUES; STAPHYLOCOCCUS AUREUS;

ANIMALIA; CANIS FAMILIARIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036689425     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0450.2002.00568.x     Document Type: Article

References (45)

1. Activity of free and liposome encapsulated streptomycin against Mycobacterium avium compex (MAC) inside peritoneal macrophages
2. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatments of infections
3. Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish shepherd dog neutrophils in vitro
4. Results of clinical studies with Baytril in dogs and cats
5. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits
6. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages
7. Liposomes and nanoparticles in the treatment of intracellular bacterial infections
8. The investigation of phagocytosis of liposomes by monocytes
9. Liposome-encapsulated ciprofloxacin is effective in protection and treatment of BALB/C mice against F. tularensis
10. Treatment of mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin
11. Uptake of ciprofloxacin by human neutrophils
12. Uptake of ciprofloxacin by macrophages
13. Liposomes in treatment of infectious diseases
14. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells
15. Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes
16. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs
17. Phagocytosis of microorganism
18. Liposome pharmacokinetics
19. Simple procedure for preparing liposomes capable of high encapsulation efficiency under mild conditions
20. Factors affecting microencapsulation of drugs in liposomes
21. Effect of low intracellular pH on antimicrobial activity of antibiotics against ingested staphylococci
22. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity
23. Penetration of antibiotics into bovine neutrophils and their activity against intracellular Staphylococcus aureus
24. Liposome-incorporated ciprofloxacin in the treatment of murine salmonellosis
25. Phagolysosmal alkalinisation and intracellular killing of Staphylococcus aureus by amikacine
26. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: The Coxiella burnetii paradigm
27. Analysis of selected variables in the under-agarose assay for chemotactic response of canine neutrophils
28. The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes
29. Uptake and intracellular activity of antimicrobial agents in phagocytic cells
30. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes
31. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells
32. Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications
33. The canine monocyte
34. Studies on antimicrobial activity of Baytril
35. Concentrations of active ingredient in serum and tissues after oral and parenteral administration of Baytril
36. Effects of enrofloxacin on porcine phagocytosis function
37. Isolation and functional analysis of normal canine blood monocytes and resident alveolar macrophages
38. Accumulation and subcellular distribution of antibiotics in macrophages in relation to activity against intracellular bacteria
39. High performance liquid chromatographic for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue
40. The flouroquinolone antimicrobials: Structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity
41. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs
42. Comparative pharmacokinetic disposition of fluoroquinolones in the lung
43. Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline Anamycin incorporated in liposomes